Drug
elranatamab-bcmm
Marketed as ELREXFIO.
Generic name
elranatamab-bcmm
Brand names
ELREXFIO
First FDA approval
2023-08-14
FDA approval history
| FDA ID | Brand | Approval date | Manufacturer |
|---|---|---|---|
| BLA761345 | ELREXFIO | 2023-08-14 | PFIZER INC |
Manufacturers
PFIZER INC
Frequently asked questions
When was elranatamab-bcmm FDA approved?
Earliest FDA approval on record: 2023-08-14.
What brand names are sold as elranatamab-bcmm?
ELREXFIO.
Sources
Appeal a elranatamab-bcmm denial
Upload your denial — DenialHelp drafts a physician-ready appeal letter in five minutes with the right clinical guideline and federal regulation cited. $39 first-level, money back if we can't draft a strong appeal.
Get started →Contact: hello@denialhelp.com